What is the main purpose of the special shareholder meeting on October 19, 2017?

The special shareholder meeting is being held to obtain approval from common shareholders for proposed changes to the dividend payment tests stipulated in MetLife's charter.

What types of debt instruments are affected by the consent solicitation?

The consent solicitation affects holders of MetLife's 6.40% Fixed-to-Floating Rate Junior Subordinated Debentures due 2066, 9.250% Fixed-to-Floating Rate Junior Subordinated Debentures due 2068, 10.750% Fixed-to-Floating Rate Junior Subordinated Debentures due 2069, and MetLife Capital Trust IV's 7.875% Fixed-to-Floating Rate Exchangeable Surplus Trust Securities.

What impact might these changes have on MetLife's financial operations?

The proposed changes to dividend and interest payment tests could provide MetLife with greater financial flexibility regarding capital allocation, dividend payments to shareholders, and the management of its debt obligations. Investors should consult the definitive proxy statement for specific details on how these changes might affect the company.

Where can I find more detailed information about these proposed changes?

More detailed information, including the definitive proxy statement, will be available on the SEC's website (www.sec.gov) and MetLife's investor relations website (www.metlife.com) once filed. Investors are strongly encouraged to read these documents carefully before making any voting decisions.

METLIFE INC 8-K SEC Disclosure

Summary

MetLife Inc. (MET) filed an 8-K report on August 10, 2017, primarily announcing two significant corporate actions. The company is convening a special meeting of its common shareholders on October 19, 2017, to seek approval for modifications to the dividend payment tests outlined in MetLife's charter. Additionally, MetLife is initiating a consent solicitation from holders of specific junior subordinated debentures and trust securities to amend interest payment tests within their respective supplemental indentures. These actions suggest MetLife is proactively managing its capital structure and obligations. The proposed changes to dividend and interest payment tests are crucial for the company's financial flexibility. Investors should pay close attention to the details of these proposed amendments and their potential impact on future dividend payouts and the cost of its debt. The filing also serves as a reminder of the forward-looking nature of the company's statements and the inherent risks and uncertainties involved, urging investors to consult detailed filings for a comprehensive understanding.

Key Highlights

1MetLife is holding a special shareholder meeting on October 19, 2017, to vote on changes to its charter regarding dividend payment tests.
2The company is also soliciting consents from holders of specific junior subordinated debentures and trust securities to alter interest payment tests in their indentures.
3This indicates MetLife is undertaking actions to potentially enhance its financial flexibility and manage its capital structure.
4Investors are advised to review upcoming proxy materials for detailed information on the proposed charter and indenture amendments.
5The filing includes standard cautionary statements regarding forward-looking statements and associated risks.
6MetLife has filed preliminary proxy materials with the SEC related to the proposed charter changes.

METLIFE INC 8-K Report, Corporate Update (Aug 10, 2017)

Summary

Key Highlights

Frequently Asked Questions